title: Verapamil and hematoporphyrin derivative for tumour destruction by photodynamic therapy.
authors.affiliation: Department of Medicine, University of Erlangen-Nuremberg, Germany.
authors.forename: L
authors.initials: L
authors.lastname: Gossner
authors.forename: H
authors.initials: H
authors.lastname: Wittke
authors.forename: A
authors.initials: A
authors.lastname: Warzecha
authors.forename: R
authors.initials: R
authors.lastname: Sroka
authors.forename: H
authors.initials: H
authors.lastname: Ernst
authors.forename: M
authors.initials: M
authors.lastname: Meier
authors.forename: C
authors.initials: C
authors.lastname: Ell
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002460:Cell Line; D005260:Female; D005354:Fibrosarcoma / Q000188:drug therapy* / Q000473:pathology; D017324:Hematoporphyrin Derivative; D006415:Hematoporphyrins / Q000627:therapeutic use*; D008027:Light; D051379:Mice; D008809:Mice, Inbred C3H; D009336:Necrosis; D010778:Photochemotherapy; D011838:Radiation-Sensitizing Agents / Q000627:therapeutic use*; D012513:Sarcoma, Experimental / Q000188:drug therapy* / Q000473:pathology; D014700:Verapamil / Q000627:therapeutic use*
chemical_list: D000970:Antineoplastic Agents; D006415:Hematoporphyrins; D011838:Radiation-Sensitizing Agents; D017324:Hematoporphyrin Derivative; D014700:Verapamil